Wexecutive Breakfast series | Global Pharma Strategy and US pricing
The evolving US pharmaceutical pricing landscape is increasingly shaping global strategic decisions—from portfolio prioritization and launch sequencing to investment allocation and geographic expansion.
This event will explore how changes in US pricing dynamics may influence global pharma strategies, with a particular focus on the opportunities and challenges of expanding into emerging markets. Through industry perspectives it will be discussed how companies can adapt their commercial and geographic strategies in an increasingly complex and interconnected environment.
The event is co-organized by the University of Cambridge Alumni Interest Support Group for Health & Biotech, bringing together members of the Cambridge alumni community and industry leaders for an engaging exchange of perspectives and experiences.
A W Executive Breakfast series event
The event is organized by W Executive in collaboration with the Univeristy of Cambridge - Judge Business School Alumni Special Interest Group Health & Biotech. The event is run according to the Chatham House Rule and is kindly hosted by our partner Signature.
Stefano De Socio Lardani will be the moderator for this event.
Guest Speakers
Marco Lucchin, Partner, Wexecutive International
Bruno Parenti, Recordati Rare Diseases, Managing Director, Head of LATAM, APAC & CIS Region
Niccolo Pengo, Chief Scientific Officer, Mabylon AG
Joseph A. Meiselles, Senior Vice Presidente, Commercial, Farmamondo
Moderator
Stefano De Socio Lardani Cambridge Judge Business School, Recordati
Agenda
8.30: doors open
9.00-9.30: panel
9.30-9.45 Q&A
9.45 onwards: networking